Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 37.52% vs 28.49% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 213.44% vs 149.83% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 94.74% vs 67.06% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 288.37% vs 310.76% in Mar 2024
Compare Profit and Loss Results of Aptus Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
24.00
112.00
-88.00
-78.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
24.00
112.00
-88.00
-78.57%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-1.00
-2.00
-200.00%
Raw Materials Consumed
12.00
71.00
-59.00
-83.10%
Power & Fuel Cost
0.00
2.00
-2.00
-100.00%
Employee Cost
3.00
14.00
-11.00
-78.57%
Operating Expenses
1.00
3.00
-2.00
-66.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
8.00
-5.00
-62.50%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
5.00
-5.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
19.00
107.00
-88.00
-82.24%
Operating Profit (PBDIT) excl Other Income
4.00
5.00
-1.00
-20.00%
Other Income
0.00
23.00
-23.00
-100.00%
Operating Profit (PBDIT)
4.00
28.00
-24.00
-85.71%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
4.00
28.00
-24.00
-85.71%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
4.00
25.00
-21.00
-84.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
25.00
-21.00
-84.00%
Provision for Tax
1.00
6.00
-5.00
-83.33%
Profit After Tax
3.00
19.00
-16.00
-84.21%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
85.00
-84.00
-98.82%
Profit Available for appropriations
4.00
105.00
-101.00
-96.19%
Appropriations
4.00
105.00
-101.00
-96.19%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
6.37
9.42
-3.05
-32.38%
Profit And Loss - Net Sales
Net Sales 24.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.52% vs 28.49% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 213.44% vs 149.83% in Mar 2024
Profit And Loss - Interest
Interest 0.47 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 94.74% vs 67.06% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 3.10 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 288.37% vs 310.76% in Mar 2024






